← All trials
NCT07078344
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 31, 2025
- Primary completion
- May 31, 2029
- Completion date
- Dec 31, 2029
- First posted
- Jul 22, 2025
- Last posted
- Oct 3, 2025
- Enrollment
- 200
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of ArizonaLead sponsor
- National Center for Complementary and Integrative Health (NCCIH)Collaborator
- Georgetown UniversityCollaborator
- University of ArizonaSponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.